RNTCP Annual Report 2012 - TBC India

Procurement & Drug Logistics:
Central Procurement:-
Procurement, Supply & Logistics Unit at Central TB
Division (CTD) is functioning under the supervision of
Additional Deputy Director General (TB) who is supported
by a Procurement & Supply Management Consultant
and an agency outsourced with the assistance from
WHO for drug logistics management.
The procurement agency (M/s RITES Ltd.) undertakes
procurement of drugs under various Programme Divisions
of the MoHFW including RNTCP. The Procurement
of 1st Line Anti TB Drugs (through World Bank
funding) and procurement of 2nd line Anti-TB Drugs
(through World Bank and GLC), Laboratory Equipment
and Purified Protein Derivative (PPD) is presently being
undertaken at the Central level.
(i) Anti TB Drugs: - An uninterrupted supply of
good quality Anti TB Drugs is an essential component
of DOTS strategy under RNTCP. Supplies of Procurement
for the Year 2010-11 have been completed, except
for Inj. Streptomycin supplies which was delayed due to
delay in testing of distilled water.
(a) First Line Anti TB Drugs:-With the financial
support of DFID coming to an end in 2011, procurement
of Drugs for the entire population of the country
for both the World Bank and GFATM funded states
shall now be done through International Bidding from
'WHO Pre-Qualified suppliers' only by RITES, the procurement
agency of MoHFW (Govt. of India), following
the World Bank procurement guidelines. As no WHO
pre-qualified supplier is available for Injection Streptomycin,
the same is continued to be procured through
International Competitive Bidding.
(b) Second Line Anti TB Drugs:- The 2nd Line
Anti TB Drugs for 3450 patients under DOTS Plus is
being procured during the year 2010-11 by M/s RITES
27
Ltd.for World Bank funded states (Assam, Delhi, Goa,
H.P, Jammu & Kashmir, Maharashtra, Puducherry,
Chandigarh, Punjab) through International Competitive
Bidding (ICB). Procurement of 2nd Line Anti TB Drugs
for 11,550 pts. i.e.(GF-RCC-1200 pt.courses,GF-Rd-9-
5350 pt. courses & UNITAID-5000 pt.courses) patients
for GFATM funded states (Andhra Pradesh, Bihar, Uttar
Pradesh, Rajasthan, Tamil Nadu, West Bengal, Karnataka,
Madhya Pradesh, Gujarat, Kerala, Chhattisgarh, Haryana,
Jharkhand, Orissa and Uttrakhand) and 4,850 patients
funded by UNITAID was also done through Green
Light Committee (GLC) and Global Drug Facility
(GDF) which are part of Stop TB Partnership. The supply
of drugs procured during the year through GDF is
in process.
The procurement of 2nd Line Anti-TB Drugs for 4550
patients under World Bank and for 20,450 for GFATM
funded states for the year 2011-12 has been initiated.
Quality Assurance of 1st& 2nd Line Anti-TB
Drugs: -
Quality Assurance (QA) of Anti-TB Drugs has been accorded
special importance by RNTCP and measures are
taken to ensure both pre and post-dispatch inspection
of the Anti-TB Drugs.
(a) QA measures at the time of Procurement : -
1st line Anti-TB Drugs - Since 2008-09, procurement
of 1st Line Anti-TB Oral Drugs has been limited to
'WHO Pre-Qualified suppliers' and pre-dispatch inspection
and testing of all batches is mandatorily done. Injection
Streptomycin is procured through International
Competitive Bidding (ICB) from WHO-GMP suppliers
only, Joint Inspection for verification of WHO-GMP
Certificates by a team under DCG(I) is ensured and predispatch
inspection of all batches is done.
2nd line Anti-TB Drugs: - Procurement for the World